lysergic acid diethylamide has been researched along with Depressive Disorder, Treatment-Resistant in 2 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Tullis, P | 1 |
Rucker, JJ | 1 |
Jelen, LA | 1 |
Flynn, S | 1 |
Frowde, KD | 1 |
Young, AH | 1 |
1 review available for lysergic acid diethylamide and Depressive Disorder, Treatment-Resistant
Article | Year |
---|---|
Psychedelics in the treatment of unipolar mood disorders: a systematic review.
Topics: Depressive Disorder, Treatment-Resistant; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Di | 2016 |
1 other study available for lysergic acid diethylamide and Depressive Disorder, Treatment-Resistant
Article | Year |
---|---|
How ecstasy and psilocybin are shaking up psychiatry.
Topics: Animals; Certification; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resista | 2021 |